Company Filing History:
Years Active: 2020
Title: Innovations by Simon Krah: Unlocking Protein Display Technologies
Introduction: Simon Krah, an inventive mind based in Darmstadt, Germany, has made significant strides in the field of biotechnology. With a focus on non-covalent protein display methods, Krah's contributions have the potential to advance various applications in medical research and therapeutics.
Latest Patents: Simon Krah holds a patent titled "Methods for non-covalent Fc-domain-containing protein display on the surface of cells and methods of screening thereof." This innovative method aims to facilitate the non-covalent display of proteins of interest, including Fc-domain containing proteins such as antibodies. The patent outlines techniques that can be used for screening and selecting proteins based on desired phenotypes, while also providing methodologies for the production of associated polynucleotides and proteins.
Career Highlights: Currently, Krah works at Merck Patent GmbH, where he is dedicated to advancing biotechnological innovations. His work emphasizes the integration of scientific research with practical applications, which exemplifies the spirit of innovation in his field.
Collaborations: Throughout his career, Simon has collaborated with esteemed colleagues such as Laura Rhiel and Stefan Becker. These partnerships not only enhance his research capabilities but also foster a dynamic environment for innovation within the organization.
Conclusion: Simon Krah's innovative work in developing methods for non-covalent protein display showcases his commitment to advancing biotechnology. His contributions have the potential to influence various sectors, offering new avenues for research, and confirming the importance of collaboration in driving scientific discoveries.